PLERIXAFOR
Summary of product characteristics
Effective Time
20230728
Version
1
Spl Product Data Elements
PLERIXAFOR plerixafor PLERIXAFOR PLERIXAFOR HYDROCHLORIC ACID SODIUM CHLORIDE SODIUM HYDROXIDE WATER
Application Number
ANDA208980
Brand Name
PLERIXAFOR
Generic Name
plerixafor
Product Ndc
70771-1776
Product Type
HUMAN PRESCRIPTION DRUG
Route
SUBCUTANEOUS
Package Label Principal Display Panel
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1776-1 Plerixafor Injection – 1.2 mL vial label 24 mg/1.2 mL (20 mg/mL) For subcutaneous injection only For single-dose only Rx only NDC 70771-1776-1 Carton contains one vial of Plerixafor Injection 24 mg/1.2 mL (20 mg/mL) For subcutaneous injection only See package insert for dosage and administration For single-dose only Rx only vial label carton label
1 mins
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.